The Food and Drug Administration (FDA) has granted Fast Track designation to PP-01 (nabilone/gabapentin) for the mitigation of cannabis withdrawal ...
The designation will provide Lundbeck with the possibility of rolling reviews and detailed guidance to streamline the drug ...
A California-based biotech found some serious success on Wednesday after the company received FDA fast track designation for Troculeucel, used for the treatment of moderate Alzheimer’s disease.
The device, called TruNarc, was awarded by the Arkansas Opioid Recovery Partnership to Siloam Springs PD to help with drug detection.
Acquisition includes abelacimab, a Factor XI-inhibiting monoclonal antibody in development for stroke prevention in patients ...